MyFinsight
Home
About
Contact
stok: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, STOK has $360,264K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
360,264
384,508
Total stockholders equity
308,105
334,943
Total liabilities and stockholders equity
360,264
384,508
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Other current assets
$5,543K
Interest receivable
$1,589K
Prepaid expenses
$7,747K
Accounts receivable
$9,248K
Marketable securities -
current
$164,916K
Cash and cash
equivalents
$83,394K
Property and equipment,
net
$3,083K
Operating lease
right-of-use assets
$3,708K
Restricted cash - long-term
$721K
Marketable securities -
long-term
$80,315K
Total current assets
$272,437K
Total assets
$360,264K
Total liabilities and
stockholders equity
$360,264K
Total stockholders
equity
$308,105K
Total liabilities
$52,159K
Accumulated deficit
-$439,781K
Accumulated other
comprehensive income (loss)
$446K
Additional paid-in capital
$747,435K
Total long term
liabilities
$10,432K
Total current
liabilities
$41,727K
Common stock, par value
of 0.0001 per share...
$5K
Other long term
liabilities
$1,874K
Deferred revenue - net of
current portion
$8,558K
Deferred revenue -
current portion
$5,763K
Accrued and other
current liabilities
$30,093K
Accounts payable
$5,871K
Buy me a coffee
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK)